IVA
Twin Vee Powercats, Inc.
NASDAQ · Healthcare · Biotechnology · FR
$3.78
+0.80%Year over year
Reported trailing growth
- Revenue
- -51.3%
- EBITDA
- -46.3%
- EBIT
- -34.2%
- EPS
- +46.3%
- Free cash flow
- -25.7%
- Operating cash flow
- -25.9%
Forward estimates
Based on analyst estimates
- Revenue
- +233.4%
- EBITDA
- —
- EPS
- +15.5%
Three-year CAGR
- Revenue
- -28.3%
- EBITDA
- +23.0%
- EBIT
- -34.2%
- Net income
- -84.7%
- EPS
- +48.6%
- Free cash flow
- -17.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Dec 1, 2025